You are here

Global

Moderna, 2nd virus vaccine shows overwhelming success in U.S. tests

Moderna said Monday its COVID-19 vaccine is proving to be highly effective in a major trial, a second dash of hope in the global race for a shot to tame a resurgent virus that is now killing more than 8,000 people a day worldwide.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

International roundup of COVID-19 developments -Reuters

Reuters) - Delhi’s COVID-19 deaths rose by a record number on Thursday and it reported the most infections in India, as government officials in Germany dampened hopes that a partial lockdown there would be lifted at the end of November.

Problem, Solution, SitRep, or ?: 

What's next for COVID-19 apps? Governance and oversight

Science   Article 

Studies conducted in April and May 2020 showed that in countries like the United States, Switzerland, and Italy, between 55 and 70% of adults in all age groups were willing to download a contact tracing app (5).

Yet these figures do not match the current DCT apps uptake. Even in countries with robust privacy safeguards in place, downloads of DCT apps have been below expectations. At the time of writing, the Australian DCT app has been downloaded by 6.5 million (26% of the population), the Italian one by 8 million (13.4%), and the newly released French one by 1.5 million (2.3%). Ireland has about 1.3 million active app users (24%), Switzerland 1.8 million (21.5%), and Germany 16 million (19.3%).

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

British Study: Black people 'twice as likely to catch coronavirus'

Black people are twice as likely as white people to catch the coronavirus, a study of 18 million people suggests.

The research also indicates Asian people are 1.5 times more likely than white people to be infected - and may be more likely to need intensive care.

Problem, Solution, SitRep, or ?: 

How Pfizer Plans to Distribute Its Vaccine (It’s Complicated)

For months, scientists and public health experts have been saying the most crucial part of defusing the Covid-19 pandemic will be developing a safe and effective vaccine. So it was cause for celebration this week when Pfizer announced that an early analysis showed its vaccine candidate was more than 90 percent effective.

Now the drug maker, the government and the public health community face a new challenge: quickly making millions of doses of the vaccine and getting them to the hospitals, clinics and pharmacies where they will be injected, two separate times, into people’s arms.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Global
howdy folks